In-depth research on therapeutic peptides including BPC-157, Semax, Selank, KPV, DSIP, and more. Explore mechanisms of action, clinical studies, dosing protocols, and safety profiles backed by published science.
IGF-1 LR3 is a modified version of insulin-like growth factor with a significantly extended half-life. Explore its mechanisms for muscle growth, recovery, and cellular health.
Ipamorelin selectively stimulates growth hormone release without affecting cortisol, prolactin, or appetite. Learn why it's considered the cleanest GH secretagogue available.
PT-141 (bremelanotide) is an FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder. Learn about its unique central nervous system mechanism.
Cagrilintide is a long-acting amylin analog being studied for weight management. Learn how it differs from GLP-1 drugs, its mechanisms, and what clinical trials show.
KPV is a powerful anti-inflammatory tripeptide that inhibits NF-κB signaling. Research shows it reduces intestinal inflammation and modulates immune responses without immunosuppression.
GHK-Cu is a naturally occurring copper peptide that declines with age. Research shows it modulates over 30% of human genes, shifting expression toward a younger pattern.
Tesamorelin is the only FDA-approved GHRH analog for reducing visceral fat. Explore the clinical research, mechanisms, and what makes this peptide unique.
TB-500 is a synthetic fragment of Thymosin Beta-4 that promotes cell migration, reduces inflammation, and accelerates tissue repair. Here's what the research shows.
The definitive guide to BPC-157 — over 100 studies, multiple tissue types, and decades of research. Mechanisms, clinical applications, delivery methods, and what the science actually shows.
The KLOW protocol adds KPV's powerful anti-inflammatory action to the GLOW stack. Learn how this four-peptide combination addresses inflammation and repair simultaneously.